Grifols S.A. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.48 |
Market Cap |
$13.31 B |
Shares Outstanding |
852.26 M |
Public Float |
- |
Grifols S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Grifols S.A. ADR | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.96 |
Market Cap |
$5.58 B |
Shares Outstanding |
261.43 M |
Public Float |
- |
Address |
Avinguda de la Generalitat, 152-158 Barcelona Catalonia 08174 Spain |
Employees | - |
Website | http://www.grifols.com |
Updated | 07/08/2019 |
Grifols SA is a vertically integrated global producer of plasma derivatives. Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers. The company operates through the following segments: Bioscience, Hospital, Diagnostic and Raw Materials. |